JP2024543085A5 - - Google Patents

Info

Publication number
JP2024543085A5
JP2024543085A5 JP2024529398A JP2024529398A JP2024543085A5 JP 2024543085 A5 JP2024543085 A5 JP 2024543085A5 JP 2024529398 A JP2024529398 A JP 2024529398A JP 2024529398 A JP2024529398 A JP 2024529398A JP 2024543085 A5 JP2024543085 A5 JP 2024543085A5
Authority
JP
Japan
Prior art keywords
human gene
biomarker
polypeptide encoded
target
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024529398A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024543085A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/050327 external-priority patent/WO2023091618A1/en
Publication of JP2024543085A publication Critical patent/JP2024543085A/ja
Publication of JP2024543085A5 publication Critical patent/JP2024543085A5/ja
Pending legal-status Critical Current

Links

JP2024529398A 2021-11-17 2022-11-17 卵巣がんの検出のための組成物および方法 Pending JP2024543085A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163280603P 2021-11-17 2021-11-17
US63/280,603 2021-11-17
US202263328250P 2022-04-06 2022-04-06
US63/328,250 2022-04-06
US202263417309P 2022-10-18 2022-10-18
US63/417,309 2022-10-18
PCT/US2022/050327 WO2023091618A1 (en) 2021-11-17 2022-11-17 Compositions and methods for detection of ovarian cancer

Publications (2)

Publication Number Publication Date
JP2024543085A JP2024543085A (ja) 2024-11-19
JP2024543085A5 true JP2024543085A5 (enExample) 2025-11-26

Family

ID=86397740

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024529398A Pending JP2024543085A (ja) 2021-11-17 2022-11-17 卵巣がんの検出のための組成物および方法

Country Status (5)

Country Link
US (1) US20250327129A1 (enExample)
EP (1) EP4433827A4 (enExample)
JP (1) JP2024543085A (enExample)
CA (1) CA3238997A1 (enExample)
WO (1) WO2023091618A1 (enExample)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140271453A1 (en) * 2013-03-14 2014-09-18 Abbott Laboratories Methods for the early detection of lung cancer
CN113748217B (zh) * 2019-03-01 2023-08-25 仁慈生物分析公司 用于靶实体检测的系统、组合物和方法
US20230243834A1 (en) * 2020-01-17 2023-08-03 Mercy Bioanalytics, Inc. Compositions and methods for detection of ovarian cancer

Similar Documents

Publication Publication Date Title
JP2022521781A5 (enExample)
JP7344973B2 (ja) 標的実体を検出するためのシステム、組成物、及び方法
JP2023533970A5 (enExample)
JP6285009B2 (ja) 前立腺ガンの予後の検知及び判定のための組成物及び該検知及び判定方法
KR20230044429A (ko) 폐암의 검출을 위한 조성물 및 방법
JP2016505247A5 (enExample)
JP2025504786A5 (enExample)
Wang et al. Immunomagnetic antibody plus aptamer pseudo-DNA nanocatenane followed by rolling circle amplication for highly-sensitive CTC detection
JP2023510911A5 (enExample)
CN115279920A (zh) 用于检测卵巢癌的组合物和方法
KR20230025895A (ko) 순환 종양 핵산 분자의 다중모드 분석
US20250223649A1 (en) Compositions and methods for detection of lung cancer
WO2023004083A2 (en) Compositions and methods for detection of bile duct cancer
JP2024529386A5 (enExample)
CN112662770A (zh) 一种肺癌检测联合标志物、检测产品及其用途
US11519042B2 (en) Method for the diagnosis or prognosis, in vitro, of lung cancer
US11453920B2 (en) Method for the in vitro diagnosis or prognosis of ovarian cancer
US11473147B2 (en) Method for the diagnosis or prognosis, in vitro, of testicular cancer
JP2024543085A5 (enExample)
Wang et al. t (11; 18)(q21; q21) in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in stomach: a study of 48 cases
JP2015506165A (ja) 大腸癌のインヴィトロ診断又は予後予測方法
JPWO2015137406A1 (ja) 肺扁平上皮癌と肺腺癌の鑑別評価方法
JP2024529918A5 (enExample)
JP2024529918A (ja) 結腸直腸がんの検出のための組成物および方法
US11459605B2 (en) Method for the diagnosis or prognosis, in vitro, of prostate cancer